germany
germany · page 7
- Medical
‘Incredibly Bullish’: How Canada’s Biggest Cannabis Players Are Conquering Europe (Part 2)
With Aurora Cannabis and High Tide consolidating their presence across Europe, with a focus on Germany, how will this lucrative supply chain be impacted by shifting geopolitical dynamics?
- Markets & Stocks
Aurora & Demecan Launch First German-Grown Products, Stenocare Exits Cultivation Facility, & More From Cantourage
Stenocare Danish medical cannabis oil producer Stenocare has exited its cultivation facility in Denmark, just four years after it was completed.
- Medical
Will Germany’s Medical Cannabis Boom Survive the February Election?
A month out from Germany’s federal election, alarm bells are ringing for the booming cannabis market.
- Press releases
Prime Minister Kretschmer of Saxony Visits Cannabis Group Grünhorn: “The Market for Medical Cannabis Has Great Potential”
Today’s visit by Prime Minister Michael Kretschmer, part of the CDU, a party known for its critical stance on cannabis, to Grünhorn in Leipzig marks a significant milestone in the political recognition of cannabis as a plant-based medicine.
- Markets & Stocks
High Tide Breaks into German Market, Cantourage Exceeds Projections in 2024, & More from SEED
Cantourage [stock_market_widget type=”chart” template=”line” assets=”HIGH.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Berlin-based medical cannabis company Cantourage saw sales exceed its own projections in 2024, with sales more than doubling on 2023.
- Adult-Use
‘The Way is Clear’: German Municipalities Gear Up for Cannabis Research Pilots
‘The way is clear’ for Germany’s growing list of municipalities, universities and cannabis businesses to launch model research projects into adult-use cannabis.
- Medical
Germany’s Medical Cannabis Imports Grow 70% in Q3 as Market Explosion Continues
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has published the medical cannabis import figures for Q3, showing that the country’s medical cannabis market is still growing rapidly.
- Policy & Regulation
Germany’s Poll-Leading Party Eyes Rollback of Cannabis Reforms as Elections Loom
While little common ground was found during Friday’s debate, the well-trodden rhetoric from each side emphasised that the implementation of CanG remains a controversial and divisive issue in Germany.
- Policy & Regulation
What Does the Collapse of Germany’s Government Mean for Cannabis?
Mere hours after the results of the US election became clear, sending North American cannabis stocks into freefall, Germany’s ruling traffic light coalition all but collapsed, throwing the future of Europe’s largest and most promising cannabis market into uncertain territory.
- Adult-Use
Germany Announces 2 Further Planned Adult-Use Cannabis Trials, but Legislation Not Yet in Place to Launch Them
Last week, Hanover and Frankfurt published ‘letters of intent’ to launch controlled cannabis sales to thousands of participants through new model projects, designed to gather data and inform future drug policy in Germany.
- Medical
German Doctors Can Now Prescribe Reimbursed Medical Cannabis Without Prior Approval, But Cannabis Sentiment Wanes
From October 17, the majority of doctors in Germany will be able to prescribe medical cannabis for reimbursement without securing prior approval of the health insurance companies.
- Data & Analysis
German Medical Cannabis Market to Top €420m in 2024 Amid ‘Second Wave of German Cannabis’
Germany’s flourishing medical cannabis market is now forecast to top €420m this year, according to Prohibition Partners’ upcoming German Cannabis Report.
